Zucchetti Giulia, Candela Filippo, Bottigelli Cristina, Campione Gabriela, Parrinello Annalisa, Piu Paola, Vassallo Elena, Fagioli Franca
1 Regina Margherita Children's Hospital, A.O.U. Città della Salute e della Scienza, Turin, Italy.
2 University of Turin, Turin, Italy.
J Pediatr Oncol Nurs. 2019 Sep/Oct;36(5):361-368. doi: 10.1177/1043454219845879. Epub 2019 May 3.
Reiki is a growing complementary therapy in pediatric oncology that needs evidence to become more credible among the health community. A within-subject design experiment was conducted to pilot testing the feasibility and efficacy of Reiki to provide pain relief among pediatric patients undergoing hematopoietic stem cell transplantation (HSCT). : Pediatric patients undergoing HSCT during the inpatient phase in the Stem Cell Transplantation Unit were eligible to participate to the pilot study. Short and medium effects were assessed investigating the increase or decrease of patient's pain during three specific time periods ("delta") of the day: morning of the Reiki session versus assessment before Reiki session (within subjects control period), assessment before Reiki session versus assessment after Reiki session (within subjects experimental period) and assessment after Reiki session versus morning the day after Reiki session (within subject follow-up period). The long-term effects were verified comparing the pain evolution in the day of the Reiki session with the following rest day. The effect of 88 Reiki therapy sessions in nine patients (M = 12; Female = 61%) was analyzed following a short, medium, and long-term perspective. Repeated-measures analysis of variance revealed a significant difference among the three periods ( = 17,17 < .0001): A decrease of the pain occurred in the experimental period in short and medium term, while in the follow-up period, the pain level remained stable. This study demonstrates the feasibility of using Reiki therapy in pediatric cancer patients undergoing HSCT. Furthermore, these findings evidence that trained pediatric oncology nurses can insert Reiki into their clinical practice as a valid instrument for diminishing suffering from cancer in childhood.
灵气疗法是儿科肿瘤学中一种日益受到关注的辅助疗法，需要有证据才能在医疗界更具可信度。我们进行了一项受试者内设计实验，以初步测试灵气疗法在接受造血干细胞移植（HSCT）的儿科患者中缓解疼痛的可行性和疗效。干细胞移植病房住院阶段接受HSCT的儿科患者有资格参与该初步研究。通过调查患者在一天中三个特定时间段（“差值”）的疼痛增减情况来评估短期和中期效果：灵气治疗当天上午与灵气治疗前评估（受试者内对照期）、灵气治疗前评估与灵气治疗后评估（受试者内实验期）以及灵气治疗后评估与灵气治疗后第二天上午（受试者内随访期）。通过比较灵气治疗当天与随后休息日的疼痛演变情况来验证长期效果。我们从短期、中期和长期角度分析了9名患者（平均年龄12岁；女性占61%）接受的88次灵气治疗的效果。重复测量方差分析显示三个时期之间存在显著差异（F = 17.17，P < .0001）：在实验期，短期和中期疼痛有所减轻，而在随访期，疼痛水平保持稳定。这项研究证明了在接受HSCT的儿科癌症患者中使用灵气疗法的可行性。此外，这些发现表明，经过培训的儿科肿瘤学护士可以将灵气疗法纳入其临床实践，作为减轻儿童癌症痛苦的有效手段。
